Table 1 Overall CD10 expression according to the histologic grade and pathologic stage
From: CD10 expression in urothelial carcinoma of the bladder
| Â | CD10 | Total | |||
|---|---|---|---|---|---|
| Â | Negative No. (%) | Positive No. (%) | Â | ||
Grade | Â | Â | Â | Â | Â |
Low-grade | 186 | (83.8%) | 36 | (16.2%) | 222 (59.8%) |
High-grade | 28 | (18.8%) | 121* | (81.2%) | 149 (40.2%) |
Stage | Â | Â | Â | Â | Â |
pTa | 204 | (73.1%) | 75 | (26.9%) | 279 (75.2%) |
pT1 | 8 | (15.1%) | 45* | (84.9%) | 53 (14.3%) |
pT2-3 | 2 | (5.1%) | 37* | (94.9%) | 39 (10.5%) |